(26 days)
For the incision, excision, ablation, vaporization, hemostasis, and treatment of oral soft tissue.
Examples:
Excisional and incisional biopsies
Exposure of unerupted teeth
Fibroma removal
Gingivoplasty
Hemostasis and coagulation
Incision and drainage of abscess
Operculectomy
Pulpotomy
Reduction of gingival hypertrophy
Soft Tissue crown lengthening
Vestibuloplasty
Laser Soft Tissue Curettage
Tissue Retraction
Frenectomy and Frenotomy
Gingival Troughing for crown impressions
Gingivectomy
Ginigival incision and excision
Implant Recovery
Leukoplakia
Oral papillectomies
Pulpotomy as an adjunct to root canal therapy
Reduction of bacterial level (decontamination) and inflammation
Treatment of aphthous ulcers
Lesion (tumor) removal
Treatment of canker sores, herpetic and other ulcers of the oral mucosa
Removal of Diseased, Inflamed and necrotic soft tissue within the periodontal pocket
Removal of highly inflamed edematous tissue affected by bacteria penetration of the pocket lining and junctional epithlium
Sulcular debridement (removal of necrotic, diseased or inflamed soft tissue in the periodontal pocket to improve clinical indices ingluding gingival index, gingival bleeding index, probe depth, attachment loss and tooth mobility
Light activation of bleaching materials for teeth whitening
Laser-assisted whitening/bleaching of teeth
The laser source of the QuickLase™DUALDental Lasers or QuickLase™810/980 Dental Laser is an array of Gallium Aluminum Arsenide (GaAlAs), solid state, semiconductor diode lasers. The individual lasers comprising the array are capable of producing invisible infrared laser energy at either 810 or 980 nanometers depending upon the concentration of and construction of the epitaxial layers of the diode. The delivery system consists of a fiber optic cable with a nominal diameter of 400 microns. In all available configurations, that portion of the delivery system that is handled by the operator and/or in contact with the patient can be sterilized by heat, steam, gas, chemicals or combinations thereof. Activation of the laser occurs after the operator either selects or enters the parameters for the procedure, verifies and authorizes the parameters and depresses a footswitch which fires the laser. The footswitch is an on/off switch. The interface for input is electro-mechanical by way of a membrane switch pad. The laser operates in continuous wave or pulse mode which is selected and/or verified by the operator. A visible aiming beam is provided in the form of a visible red laser which emits not more than 5mW (user adjustable and verified) in the 640-650 nanometer wavelength range.
The provided text is a 510(k) summary for the QuickLase™DUAL+ Dental Laser. It primarily focuses on demonstrating substantial equivalence to previously cleared predicate devices, rather than presenting a de novo study with acceptance criteria and detailed performance data.
Here’s an analysis based on the provided document:
1. Table of Acceptance Criteria and Reported Device Performance
The document does not define specific quantitative acceptance criteria for its performance. Instead, it relies on the predicate devices' prior clearance and asserts identical performance.
| Acceptance Criteria (Explicitly Stated in Document) | Reported Device Performance (as stated in document) |
|---|---|
| Not explicitly stated. The core claim is "substantial equivalence" to predicate devices cleared under K072995. | "Not substantially equivalent to, they are identical in terms of safety and efficacy." (Page 2) |
| Performance requirements of 21 CFR 1040.10 and 1040.11, with permissible deviations relative to Laser Notice 50, Dated July 26, 2001. | Device complies with these performance requirements. (Page 3) |
| Compliance with international standards including IEC 60601 and 13485 Standards. | Device tested by Notified Body, CE marked, and complies with these standards. (Page 3) |
| Power densities for treatment are identical to predicate devices. | Tests confirm power densities are identical in all devices, ensuring the exact same efficacy. (Page 3) |
| Similar methods of control, safety features, and performance monitoring to predicate devices. | All comparable devices share similar methods of control, safety features, and performance monitoring. (Page 3) |
2. Sample Size Used for the Test Set and Data Provenance
- Test Set Sample Size: Not applicable. The submission is based on demonstrating identity/substantial equivalence to a previously cleared device, not on new clinical performance data for the QuickLase™DUAL+.
- Data Provenance: The document states, "These lasers have performed flawlessly in Europe in thousands of procedures over the past 2 years." (Page 2). This implies retrospective observational data from Europe, but no specific study or data set is presented. This is presented as anecdotal evidence supporting the device's history, rather than formal clinical trial data used for the 510(k) clearance.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications
Not applicable, as no new test set requiring expert ground truth establishment was conducted or reported for this 510(k) submission.
4. Adjudication Method
Not applicable, as no new test set requiring adjudication was conducted or reported for this 510(k) submission.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done
No, an MRMC comparative effectiveness study was not done. The submission explicitly states "Clinical Performance: None" (Page 3).
6. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) Was Done
Not applicable. This device is a laser surgical instrument, not an AI/algorithm-based diagnostic or therapeutic tool.
7. The Type of Ground Truth Used
Not applicable, as no new test set requiring ground truth was presented. The basis for clearance is the assertion of identity and substantial equivalence to previously cleared predicate devices (TwinWave and TidalWave by Lumen Development and Manufacturing, Inc., K072295). The implicit "ground truth" is that the predicate devices were deemed safe and effective in their previous clearance.
8. The Sample Size for the Training Set
Not applicable. This device is a physical laser system, not an AI/machine learning algorithm that requires a training set.
9. How the Ground Truth for the Training Set Was Established
Not applicable. As noted above, this involves a physical medical device, not an AI/machine learning algorithm.
Summary of the Study that Proves Acceptance Criteria:
The "study" presented here is not a traditional clinical trial or performance study with defined acceptance criteria and corresponding results. Instead, it is a demonstration of substantial equivalence to predicate devices that have already received FDA clearance.
The key points of the "proof" are:
- Identity with Predicate Devices: The QuickLase devices are declared to be "identical in terms of safety and efficacy" to the TwinWave and TidalWave devices previously cleared under K072995. The only differences are brand name and cosmetic housing variations (Page 2).
- Non-Clinical Performance Testing: "Tests confirm that the power densities for treatment are identical in all devices insuring that all devices provide the exact same efficacy." (Page 3). This implies engineering and bench testing to verify physical parameters match the predicate.
- Compliance with Standards: The device complies with relevant performance standards (21 CFR 1040.10 and 1040.11) and international standards (IEC 60601 and 13485), as evidenced by CE marking (Page 3).
- Similar Specifications: Detailed comparison showing comparable energy density, fiber delivery systems, aiming beams, physical specifications, methods of control, safety features, and performance monitoring to the predicate and other comparable devices (Page 3).
- History of Use: "These lasers have performed flawlessly in Europe in thousands of procedures over the past 2 years." (Page 2). This serves as real-world evidence of safety and efficacy, albeit not a formal clinical trial for this specific 510(k) submission.
In essence, the "study" is a technical comparison and assertion of equivalence based on the device being functionally identical to one already deemed safe and effective by the FDA.
{0}------------------------------------------------
QuickLase Limited Traditional 510(K)-QuickLase™DUAL+ QuickLase™ 810/980
510(K) Summary
し QuickLase Limited
MAR 1 6 2010
| Submitter: | QuickLase LimitedRosalind NahabDirector18 Dover StreetCanterbury, Kent CT1 3HDUnited Kingdom | MAR 1 6 2010 |
|---|---|---|
| Preparer & Contact: | Calvin D. OstlerAgent and E-contactPO Box 12641094 West Greasewood DriveRiverton, Utah 84065Phone: 801-831-5331Email: CalOstler@msn.com | |
| Preparation Date: | February 9, 2010 | |
| Device Trade Name: | QuickLase™DUAL+ Dental LaserQuickLase™ (810nm) Dental LasersQuickLase™ (980nm) Dental Lasers | |
| Common Name: | Dental Diode Laser | |
| Classification Name: | Instrument, surgical, powered, laser | |
| Regulation Description: | 878.4810 Laser surgical instrument for use in general andplastic surgery and dermatologyA. Identification.(1) A carbon dioxide laser for use in general surgery and indermatology is a laser device intended to cut, destroy, orremove tissue by light energy emitted by carbon dioxide(2) An argon laser for use in dermatology is a laser deviceintended to destroy or coagulate tissue by light energyemitted by argon.B. Classification(1) Class II | |
| Product Code: | GEX |
This document including any attachments may confidential information, privileged material or otherwise constitute non-public information by contract of all alle contain proprietary, contestial merinent pronogother than the intended pay is prohibited. I four niomation by contact of law. Any been mornition the Reserved the Research on one of the more of the more of the semination, verieted ins occanent in effor, please inniedately lectific and action of your of real of your your your versions is not authorized and may be inlay be in
{1}------------------------------------------------
| Device Class | 2 |
|---|---|
| Review Panel | General & Plastic Surgery |
| Equivalent Device: | TwinWave and TidalWave by Lumen Development andManufacturing, Inc., a California Corporation, K072295ANDDioDent Micro 980/810 by Hoya Conio, Inc, K063384Odyssey Navigator Diode Laser by Ivoclar Vivadent Inc,K062258SIROLaser by Sriona Dental Systems, GmbH, K053161LaserSmile by BioLase Technology, Inc., K030539 |
| Device Description: | The laser source of the QuickLase™DUALDental Lasers orQuickLase™810/980 Dental Laser is an array of GalliumAluminum Arsenide (GaAlAs), solid state, semiconductordiode lasers. The individual lasers comprising the array arecapable of producing invisible infrared laser energy at either810 or 980 nanometers depending upon the concentration ofand construction of the epitaxial layers of the diode. Thedelivery system consists of a fiber optic cable with a nominaldiameter of 400 microns. In all available configurations, thatportion of the delivery system that is handled by the operatorand/or in contact with the patient can be sterilized by heat,steam, gas, chemicals or combinations thereof. Activation ofthe laser occurs after the operator either selects or entersthe parameters for the procedure, verifies and authorizes theparameters and depresses a footswitch which fires the laser.The footswitch is an on/off switch. The interface for input iselectro-mechanical by way of a membrane switch pad. Thelaser operates in continuous wave or pulse mode which isselected and/or verified by the operator. A visible aimingbeam is provided in the form of a visible red laser whichemits not more than 5mW (user adjustable and verified) inthe 640-650 nanometer wavelength range. |
| Intended Use: | The QuickLase™DUALand QuickLase™810/980 DentalLasers are intended for incision, excision, ablation,vaporization, and/or coagulation of oral soft tissues(including marginal and interdental gingival and epitheliallining of free gingiva). It is also intended for light activation |
nomarios by onlast of als costined the mornition that in the more one that in home of the provincial of por system.
There received this document in entremation contained nee
{2}------------------------------------------------
for bleaching materials for teeth whitening, and laser assisted bleaching/whitening for teeth whitening.
Comparison:
The QuickLaseDUAL, QuickLase810, and QuickLase980, Diode Dental Laser Systems in their various configurations are, in fact, the TwinWave, TidalWave810, and TidalWave980 Diode Dental Lasers Systems that were cleared by the FDA on December 18, 2007 under 510(K) Number: K072995. The applications having been submitted by Lumen Development and Manufacturing, Inc. a California Corporation. We, QuickLase Limited, entered into a joint development agreement for these devices and, by the terms of the contract, were given rights in Europe. We obtained CE testing and marking and launched these lasers under the tradename QuickLaseDUAL+, QuickLase810, and QuickLase980. These lasers have performed flawlessly in Europe in thousands of procedures over the past 2 years. Lumen Development and Manufacturing, Inc., a California Corporation, fell under hard times and is out of business. According to the terms in our contract we are now able to market the devices in the USA. We are, therefore, applying for 510(K) clearance from the FDA for marketing the devices in the USA. With a notable caveat; these lasers are not substantially equivalent to, they are identical in terms of safety and efficacy. The only difference between the approved devices under 510(K) number K072995 and the devices covered in this application are the brandname change from TwinWave, TidalWave 810, and TidalWave980 to, QuickLaseDUAL+, QuickLase810, and QuickLase980 respectively, and some cosmetic differences in the housings. The units operate exactly the same and produce exactly the same results.
None the less, we offer the exact same narrative in this Summary as was submitted in and cleared in 510(k) Number K072995:
This document including any attachments may confidential information, privileged material or other wise and in and in and in and in and in and in and in and in and in and nt in the booking any elterments hay online propriodary, somiterials by anyone other than the interest prohibited. If your in the interest probles of your homilation by contact of raw. Ally disernent and in the remation the risens of the recomment. Use, dissemination, and may and may and may and may any ve received in enot, press infinedicty fective information contained herein by united by sons is not authorized and may be unlawful.
{3}------------------------------------------------
QuickLase Limited
Traditional 510(K)-QuickLase™DUAL+ QuickLase™ 810/980
The QuickLase™DUALDental Laser produces a power range of . 1-5 Watts of 980nanometer laser energy and .1-5watts of 810nanometer laser energy; a combination of .1-10watt of invisible infrared energy. The QuickLase™810/980 980 Dental Laser produces a power range of .1-10 Watts of 980nanometer invisible infrared energy. The QuickLase™810/980 810 Dental Laser produces a power range of .1-10 Watts of 810nanometer invisible infrared energy. An operator adjustable visible red aiming beam is incorporated by way of solid state 640-650nanometer range solid state lasers with a maximum output of 5 milliwatts. The energy is delivered through 400 micron diameter optical fiber. All four of the comparable devices deliver comparable energy density through identical or similar/comparable fiber delivery systems; therapeutic results are identical. The SiroLaser and DioDent Micro 980 are rated at 7 and 3watts (respectively) of 980nanometer laser energy. The LaserSmile and Navigator are rated at 10 and 3 watts (respectively) of 810nanometer laser energy. All comparable devices have aiming beams and similar physical specifications. All devices share similar methods of control, safety features and performance monitoring. The device complies with the performance requirements of
Performance Standards: 21 CFR 1040.10 and 1040.11, with permissible deviations relative to Laser Notice 50, Dated July 26, 2001. The device has been tested by Notified Body and are CE mark and thereby complies with other international standards including IEC 60601 and 13485 Standards.
Clinical Performance: None
Non-Clinical Performance: Tests confirm that the power densities for treatment are identical in all devices insuring that all devices provide the exact same efficacy. Similar power density and safety controls insure equivalent or superior safety performance to the comparison device. Please see attached data summary.
None requested at this time. Additional Information:
The QuickLase™DUAL Dental Laser or The Conclusions: QuickLase™810/980 Dental Laser are, in terms of Safety and Efficacy, exactly the same as the TwinWave and TidalWave devices cleared in 510(K) number K072295 and
This document including ary attachments may confidential information, privileged material or otherwise constitute non-public information by contract or law. Any use of this document and it contains by anyone other than the intended pary is prohibited. If you have received this document in eror, please immediately return I to QuickLase Limited and delete any copies from your system. Use, dissemination, distribution or reproduction of the information contained herein by unintended persons is not authorized and may be unlawful.
{4}------------------------------------------------
QuickLase Limited Traditional 510(K)-QuickLase™DUAL+ QuickLase™ 810/980
are only different in Brandname and certain cosmetic differences in the housings. Additionally, the QuickLase™DUAL Dental Laser or The QuickLase™810/980 Dental Laser are substantially equivalent to the listed devices without raising any issues of safety or efficacy. The device shares similar intended uses, and similar functional and performance characteristics. The device is designed to and its components have been evaluated and/or tested to comply with or exceed relevant federal safety and performance standards.
This document including any attachments may confidential information, privileged material or otherwise constitute non-public information by contract or law. Any use of this document and it contains by anyone other than the intended party is prohibited. If you have received this document in error, please imited and delete any copies from your system. Use, disemination, distribution or repoduction of the information contained herein by unintended persons is not authorized and may be vilaw[i].
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, symbolizing protection and service. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" are arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
MAR 1 6 2010
QuickLase Limited % QuickLase - Engineering and Regulatory Consulting Mr. Calvin Ostler P.O. Box 1264, 1094 West Greasewood Drive Riverton, Utah 84065
Re: K100474 . Trade/Device Name: QuickLase™DUAL+ Dental Laser QuickLase™ (810nm) Dental Lasers
QuickLase™ (980nm) Dental Lasers Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and Plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX Dated: February 27, 2010 Received: March 09, 2010
Dear Mr. Ostler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{6}------------------------------------------------
Page 2 - Mr. Calvin Ostler
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
folh
Mark N. Melkerson Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{7}------------------------------------------------
Indications for Use
510(k) Number: K100474
Device Name: QuickLase™DUAL+ Dental Laser, QuickLase™ 810 Dental Lasers, QuickLase™ 980 Dental Lasers
Indications for Use: For the incision, excision, ablation, vaporization, hemostasis, and treatment of oral soft tissue.
| Examples: | |
|---|---|
| Excisional and incisional biopsies | Frenectomy and Frenotomy |
| Exposure of unerupted teeth | Gingival Troughing for crown impressions |
| Fibroma removal | Gingivectomy |
| Gingivoplasty | Ginigival incision and excision |
| Hemostasis and coagulation | Implant Recovery |
| Incision and drainage of abscess | Leukoplakia |
| Operculectomy | Oral papillectomies |
| Pulpotomy | Pulpotomy as an adjunct to root canal therapy |
| Reduction of gingival hypertrophy | Reduction of bacterial level (decontamination) and inflammation |
| Soft Tissue crown lengthening | Treatment of aphthous ulcers |
| Vestibuloplasty | Lesion (tumor) removal |
| Laser Soft Tissue Curettage | Treatment of canker sores, herpetic and other ulcers of the oral mucosa |
| Tissue Retraction |
Removal of Diseased, Inflamed and necrotic soft tissue within the periodontal pocket Removal of highly inflamed edematous tissue affected by bacteria penetration of the pocket lining and junctional epithlium
Sulcular debridement (removal of necrotic, diseased or inflamed soft tissue in the periodontal pocket to improve clinical indices ingluding gingival index, gingival bleeding index, probe depth, attachment loss and tooth mobility Light activation of bleaching materials for teeth whitening
Laser-assisted whitening/bleaching of teeth
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Explus Division of Surgical, Orthopedic, and Restorative Devic Page 1 of 1 This document including any attachments may confidential information, privileged material or otherwise constitute non-publi
information by contract or law. Any use of this document and it contains by anyone other than the intended party is prohibiled. If you have received this document in error, please imited and delete any copies from your system. Use, dissenination distribution, or reproduction of the information contained herein by unintended persons is not authorized and may be unlawful
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.